Let me guess the next 6 months. Capital raising at higher SP for pipeline expansion and market penetration followed by shorting/pushing it back down to 30 cents.
Having said this, the tech and management plan seem good. Like all other Australian small biotech companies, how does one predict profitablity?
Ann: Becoming a substantial holder, page-7
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
